Cathie Wood Just This Biotech Bet: Reading the Signals
ARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
This intro examines risk profiles for index vs target date funds, offering a clear take on volatility, diversification, and potential drawdowns.
24,893 articlesARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Bridgewater Associates tightened its tech exposure in the latest 13F filing, cutting stakes in Microsoft, Meta, and A...
A new PAC targets software developers with policy safeguards as the 2026 midterms loom. It pledges to back candidates...
Warren Buffett recently shifted how he gives and invests, reportedly donating billion in Berkshire Hathaway stock whi...
Institutional moves can reveal much about a company’s future. This article breaks down why long path partners buys Al...
Wellness trends often collide with budgets. This article breaks down the financial trade-offs of preventive care, the...
Khloé Kardashian’s heartfelt tribute to her grandma MJ goes beyond memories. This article turns that moment into acti...
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...
A casual farm moment turns into a masterclass in budget-friendly self-care. Learn practical steps to embrace natural ...
Liquid crypto funds have expanded rapidly, but a looming data and workflow gap threatens risk controls as DeFi strate...
Private markets are stuck in a funding logjam, with longer waiting times and shrinking payouts, signaling that the ci...
Glamour and money collide at fashion week, but the real story lies in how high-profile families manage their finances...